BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36096813)

  • 1. Increased healthcare costs by later stage cancer diagnosis.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    BMC Health Serv Res; 2022 Sep; 22(1):1155. PubMed ID: 36096813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States.
    McGarvey N; Gitlin M; Fadli E; Chung KC
    J Med Econ; 2023; 26(1):1318-1329. PubMed ID: 37907436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of cancer management by stage at diagnosis among Medicare beneficiaries.
    Reddy SR; Broder MS; Chang E; Paydar C; Chung KC; Kansal AR
    Curr Med Res Opin; 2022 Aug; 38(8):1285-1294. PubMed ID: 35285354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of care for elderly cancer patients in the United States.
    Yabroff KR; Lamont EB; Mariotto A; Warren JL; Topor M; Meekins A; Brown ML
    J Natl Cancer Inst; 2008 May; 100(9):630-41. PubMed ID: 18445825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-cost imaging in elderly patients with stage IV cancer.
    Hu YY; Kwok AC; Jiang W; Taback N; Loggers ET; Ting GV; Lipsitz SR; Weeks JC; Greenberg CC
    J Natl Cancer Inst; 2012 Aug; 104(15):1164-72. PubMed ID: 22851271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1209-1218. PubMed ID: 30796156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
    Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
    Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of Cancer Care Across the Disease Continuum.
    Kaye DR; Min HS; Herrel LA; Dupree JM; Ellimoottil C; Miller DC
    Oncologist; 2018 Jul; 23(7):798-805. PubMed ID: 29567821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incremental Health Care Costs of Anxiety and Depression Among Medicare Beneficiaries With Cancer.
    Birch K; Chung S; Zion SR; MacEwan JP; Malecki MJ
    JCO Oncol Pract; 2023 May; 19(5):e660-e671. PubMed ID: 36800552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obtaining long-term disease specific costs of care: application to Medicare enrollees diagnosed with colorectal cancer.
    Brown ML; Riley GF; Potosky AL; Etzioni RD
    Med Care; 1999 Dec; 37(12):1249-59. PubMed ID: 10599606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
    Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
    JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival, healthcare resource use and costs among stage IV ER + breast cancer patients not receiving HER2 targeted therapy: a retrospective analysis of linked SEER-Medicare data.
    Lang K; Huang H; Sasane M; Paly VF; Hao Y; Menzin J
    BMC Health Serv Res; 2014 Jul; 14():298. PubMed ID: 25008431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs Around the First Year of Diagnosis for 4 Common Cancers Among the Privately Insured.
    Shih YT; Xu Y; Bradley C; Giordano SH; Yao J; Yabroff KR
    J Natl Cancer Inst; 2022 Oct; 114(10):1392-1399. PubMed ID: 36099068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Treatment Costs for Breast Cancer, by Tumor Stage and Type of Service.
    Blumen H; Fitch K; Polkus V
    Am Health Drug Benefits; 2016 Feb; 9(1):23-32. PubMed ID: 27066193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoperative care to manage sacroiliac joint disruption and degenerative sacroiliitis: high costs and medical resource utilization in the United States Medicare population.
    Ackerman SJ; Polly DW; Knight T; Holt T; Cummings J
    J Neurosurg Spine; 2014 Apr; 20(4):354-63. PubMed ID: 24527824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis.
    Grady I; Grady S; Chanisheva N
    Eur J Health Econ; 2021 Dec; 22(9):1365-1370. PubMed ID: 34008086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Medical Care Cost by Service Type for Patients With Recurrent and De Novo Advanced Cancer.
    Banegas MP; Hassett MJ; Keast EM; Carroll NM; O'Keeffe-Rosetti M; Fishman PA; Uno H; Hornbrook MC; Ritzwoller DP
    Value Health; 2022 Jan; 25(1):69-76. PubMed ID: 35031101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization.
    Chastek B; Kulakodlu M; Valluri S; Seal B
    Postgrad Med; 2013 Mar; 125(2):73-82. PubMed ID: 23816773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population.
    Shah R; Corman S; Shah A; Kebede N; Nwankwo C
    J Med Econ; 2021; 24(1):1221-1230. PubMed ID: 34686073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.